Statistical models for predicting a beneficial response to interferon-α in patients with chronic hepatitis B

Journal of Viral Hepatitis

Volumn 5, Issue 2, 1998, Pages 105-114

  Lau, D T Y ^a   Comanor, L ^b   Minor, J M ^b   Everhart, J E ^a   Wuestehube, L J ^b   Hoofnagle, J H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cirrhosis; HBV DNA; Hepatitis B; Linear regression; Logistic regression; Neural network

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; CHRONIC HEPATITIS; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNOTHERAPY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ANTIVIRAL AGENTS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2B; LOGISTIC MODELS; MODELS, BIOLOGICAL;

EID: 0031829786     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1998.00087.x     Document Type: Article

References (20)

1. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin N Am 1994; 23: 437-455.
2. Alexander GJM, Brahm J, Fagan EA et al. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987; 1: 66-68.
3. Hoofnagle JH, Peters MG, Mullen KD et al. Randomized controlled trial of recombinant human α-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95: 1318-1325.
4. Brook MG, McDonald JA, Karayiannis P et al. Randomized controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection. Gut 1989; 30: 1116-1122.
5. Perrillo RP, Schiff E, Davis GL et al. A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295-301.
6. Lok ASF, Wu P-C, Lai C-L et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992; 102: 2091-2097.
7. Di Bisceglie AM, Fong T-L, Fried MW et al. A randomized controlled trial of recombinant alpha interferon therapy for chronic hepatitis B. Am J Gastroenterol 1993; 88: 1887-1892.
8. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med 1993; 119: 312-323.
9. Hoofnagle JH, Di Bisceglie AM. Treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-356.
10. Baxt WG. Application of artificial neural networks to clinical medicine. Lancet 1995; 346: 1135-1138.
11. Tourassi GD, Floyd CE, Sostman HD, Coleman RE. Artificial neural network for diagnosis of acute pulmonary embolism: effect of case and observer selection. Radiology 1995; 194: 889-893.
12. Minor JM, Namini H. Analysis of clinical data using neural nets. J Biopharm Statist 1996; 6: 83-104.
13. Dybowksi R, Weller P, Chang R, Gant V. Prediction of outcome in critically ill patients using artificial neural network synthesised by genetic algorithm. Lancet 1996; 347: 1146-1150.
14. Baxt WG, Skora J. Prospective validation of artificial neural network trained to identify acute myocardial infarction. Lancet 1996; 347: 12-15.
15. Lapuerta P, Rajan S, Bonacini M. Neural networks as predictors of outcomes in alcoholic patients with severe liver disease. Hepatology 1997; 25: 302-306.
16. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
17. Hendricks DA, Stowe BS, Hoo BS et al. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 1995; 104: 537-546.
18. Miller AJ. Subset Selection in Regression, Monograph. London: Chapman and Hall, 1990: 43-84.
19. Kshirsager AM. Multivariate analysis. Multivariate Analysis, Vol. 2. Marcel Dekker, 1972: 206-243.
20. Blumberg BS. Complex interactions of hepatitis B virus with its host and environment. J R Coll Phys Lond 1995; 29: 31-40.